OVERVIEW

Proliferation of monoclonal CD1a-positive Langerhans cells that infiltrate the bronchioles and alveolar interstitium, along with lymphocytes, plasma cells, neutrophils, and eosinophils.1,2

EPIDEMIOLOGY1

Rare disease but prevalence and incidence cannot be determined due to lack of population-based studies.

  • The 5-year survival rate is 74%
  • Median survival is 12 years

RISK FACTORS1,2

  • Cigarette smoking plays a primary role
  • Men and women affected equally
  • Patients are at increased risk of cancer

The typical patient is a white smoker and 20 to 40 years old.1,2

See also

Patient Case Study 1

Test your knowledge

Take the test

bridging gaps in ILD education image

Bridging Educational Gaps in ILD

Learn more

Interstitial lung disease in systemic sclerosis with a focus on chest CT

Media Library

See Media